MSH2 and prostate carcinoma: We confirmed MSI-high status as well as loss of MSH2 and MSH6 proteins in the PBx tissue, consistent with dMMR likely present as a truncal defect in this patient's prostate cancer, which is in agreement with the findings of previous studies (Guedes et al. 2017; Fraune et al. 2020).